Presents the latest findings on the effects of pneumococcal conjugate vaccine.
Describes the development of the vaccines, their remarkable impact on respiratory and other pneumococcal infections, and the vaccines' wider impact on public health. Includes chapters on epidemiology, immunologic mechanisms, conjugation methods, antibiotic resistance, PCV immunogenicity in healthy and high-risk individuals, otitis media, and direct and indirect protective effects. Summarizes the current knowledge on pneumococcal vaccines with particular emphasis on the years after the introduction of the conjugate vaccine for professionals in academia, public health, government, or industry.
This title is published by the American Society of Microbiology Press and distributed by Taylor and Francis in rest of world territories.
